NCT07022886Active, not recruiting
INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE
Source: ClinicalTrials.gov · Last updated 30 Jul 2025
Brief summary (registry, in English)
Esophageal Achalasia has been investigated as a potential risk factor for esophageal cancer (EC). Longstanding disease, repeated treatment, age and male sex seem the most relevant risk factors, but no clear effect size estimation from large sample cohorts has been provided so far. The aim of the investigators is to estimate EC risk in large sample-size population, and to provide sub-analyses per cancer type and treatment impact on EC risk.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 47000 (actual)
- First submitted
- 8 Jun 2025
- Start date
- 3 Jun 2025
- Primary completion date
- 3 Jun 2025
- Lead sponsor
- IRCCS San Raffaele
- NCT number
- NCT07022886
What you commit to
- Study type: Observational
- Participants enrolled: 47000
- From 3 Jun 2025 to the primary completion date, 3 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Primary esophaeal and pharyngeal motility disorders (ICD-10-J39.2)
Who the study is looking for
- Esophageal achalasia diagnosed according to guidelines (ICD-10-K22.0)
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS San Raffaele Hospital Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.